Ercros, S.A.

MCE ECR.MC

Ercros, S.A. Price to Earnings Ratio (P/E) on January 14, 2025: 10.94

Ercros, S.A. Price to Earnings Ratio (P/E) is 10.94 on January 14, 2025, a 29.48% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Ercros, S.A. 52-week high Price to Earnings Ratio (P/E) is 12.86 on July 05, 2024, which is 17.51% above the current Price to Earnings Ratio (P/E).
  • Ercros, S.A. 52-week low Price to Earnings Ratio (P/E) is 7.36 on February 13, 2024, which is -32.69% below the current Price to Earnings Ratio (P/E).
  • Ercros, S.A. average Price to Earnings Ratio (P/E) for the last 52 weeks is 11.19.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
MCE: ECR.MC

Ercros, S.A.

CEO Mr. Antonio Zabalza Marti
IPO Date Jan. 3, 2000
Location Spain
Headquarters Avinguda Diagonal, 593-595
Employees 1,253
Sector Health Care
Industries
Description

Ercros, S.A. manufactures and sells basic chemicals, intermediate chemicals, and pharmaceuticals in Spain. It operates through three segments: Chlorine Derivatives, Intermediate Chemicals, and Pharmacy. The Chlorine Derivatives segment produces ammonia, bioplastics, caustic potash and soda, chlorine, chloroisocyanurates, dicalcium phosphate, dichloroethane, hydrochloric acid, hydrogen peroxide, potassium carbonate, PVC compounds, sodium chlorate and chlorite, sodium hypochlorite, and vinyl chloride monomers. This segment's products are used as intermediates in other industrial processes to purify and treat drinking and waste water; treat and maintain swimming pool water; bleach fabrics and paper; produce solvents, detergents, and strippers; manufacture printing inks and coloring; to produce compound feed and in cooling equipment. The Intermediate Chemicals segment provides formaldehyde, glues and resins, molding powders, paraformaldehyde, pentaerythritol and dipentaerythritol, and sodium formate for manufacturing chipboards, and decorative laminates and plywoods, as well as resins, paints, and varnishes in the furniture and decoration industry; plugs and switches in the electrical components sector; and household, sanitary, and packaging materials in the textile tanning industry. The Pharmacy division engages in the production of raw materials and intermediate products from antibiotic, cholesterol-lowering, anti-ulcer, and anti-fungal agents. This segment's products include amlodipine besylate, azithromycin, clarithromycin, erythromycins, famotidine, calcium and sodium fosfomycin, fosfomycin trometamol, and fusidic acid. The company is also involved in exporting activities. Ercros, S.A. was founded in 1817 and is headquartered in Barcelona, Spain.

Similar companies

FAE.MC

Faes Farma, S.A.

USD 3.46

-1.45%

ENC.MC

ENCE Energía y Celulosa, S.A.

USD 3.25

1.25%

StockViz Staff

January 15, 2025

Any question? Send us an email